<DOC>
	<DOCNO>NCT01120964</DOCNO>
	<brief_summary>This clinical trial determine safety effectiveness intravenous L-citrulline child undergo cardiopulmonary bypass heart surgery . Participants randomly assign either L-citrulline placebo ( substance medicine ) . Citrulline protein build block body convert another substance , nitric oxide ( NO ) , control blood pressure lung . Increased blood pressure lung important surgical problem ; may also lead problem follow surgery , severe high blood pressure lung ( pulmonary hypertension ) , increased time spent breathing machine , long stay intensive care unit ( ICU ) . The hypothesis study perioperative supplementation intravenous citrulline increase plasma citrulline , arginine NO metabolite prevent elevation postoperative PVT lead decrease duration postoperative invasive mechanical ventilation . The objective study determine randomize placebo control phase IB multicenter clinical trial revise protocol intravenous L-citrulline delivery give perioperatively achieve plasma citrulline level &gt; 100 umol/L child undergo surgical repair atrial septal defect , ventricular septal defect atrioventricular septal defect .</brief_summary>
	<brief_title>Intravenous L-Citrulline Treat Children Undergoing Heart Bypass Surgery : Revised Protocol</brief_title>
	<detailed_description>Increased pulmonary vascular tone ( PVT ) complicate postoperative course follow five surgical procedure congenital heart defect : 1 ) unrestrictive ventricular septal defect ( VSD ) repair ; 2 ) atrioventricular septal ( AVSD ) repair ; 3 ) arterial switch procedure transposition great artery ( TGA ) ; 4 ) bidirectional Glenn shunt procedure ; 5 ) Fontan procedure single ventricle lesion . PVT partially control NO . Arginine , precursor NO , product urea cycle . Preliminary data present regard 169 infant child undergo one six previous surgical procedure . It find urea cycle function plasma arginine level significantly decrease participant . Furthermore , participant increase PVT significantly low arginine level compare participant normal PVT . Finally , genetic single nucleotide polymorphism ( SNP ) rate limit urea cycle enzyme ( carbamyl phosphate synthetase I [ CPSl T1405N ] ) appear affect postoperative plasma arginine level PVT . It hypothesize perioperative enhancement urea cycle function key urea cycle intermediate ( citrulline ) increase plasma arginine NO metabolite prevent elevation PVT .</detailed_description>
	<mesh_term>Heart Septal Defects</mesh_term>
	<mesh_term>Heart Septal Defects , Ventricular</mesh_term>
	<mesh_term>Heart Septal Defects , Atrial</mesh_term>
	<mesh_term>Endocardial Cushion Defects</mesh_term>
	<criteria>1 . Informed Consent sign subject 's legal representative 2 . Subjects &lt; 6 year old 3 . Subjects undergo cardiopulmonary bypass repair atrial septal defect , ventricular septal defect atrioventricular septal defect 1 . Pulmonary artery vein abnormality address surgically 2 . Preoperative requirement invasive mechanical ventilation intravenous inotrope support 3 . Any condition , opinion investigator , might interfere study objective</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>